Viewing StudyNCT00689156



Ignite Creation Date: 2024-05-05 @ 7:29 PM
Last Modification Date: 2024-10-26 @ 9:50 AM
Study NCT ID: NCT00689156
Status: COMPLETED
Last Update Posted: 2018-04-05
First Post: 2008-05-29

Brief Title: Epirubicin or Not in Patients With TOP2A Topoisomerase DNA II Alpha 170kD Normal Early Breast Cancer
Sponsor: Danish Breast Cancer Cooperative Group
Organization: Danish Breast Cancer Cooperative Group

Conditions & Keywords Data

Conditions:
Name
Breast Neoplasms
Keywords:
Name View
DNA Topoisomerases Type II View
Epirubicin View
docetaxel View
Adjuvant chemotherapy View